Literature DB >> 8288315

Gamma delta T-cell lines isolated from intestinal epithelium respond to a B-cell lymphoma.

Y Sano1, E Dudley, S Carding, R H Lin, A C Hayday, C A Janeway.   

Abstract

gamma delta T-cell hybrid clones were obtained from intestinal intraepithelial lymphocytes (i-IEL) by fusion with the BW5147 thymoma line. Four clones which expressed different V gamma/V delta genes were selected for further study. All of the gamma delta clones secreted interleukin-2 (IL-2) in the presence of the BALB/c-derived B-lymphoma line, A20. No alpha beta T-cell hybrid clones derived from spleen or i-IEL responded to A20. We obtained several pieces of evidence which strongly suggest that these responses are mediated by the gamma delta T-cell receptor (TcR). Class II major histocompatibility complex (MHC), FcR and surface Ig expressed on A20 are not involved in the response. Native i-IEL derived from BALB/c selectively survive in culture in the presence of A20 cells. The ligand may be a superantigen-like molecule because all our gamma delta T-cell clones responded to A20 in spite of their different combinations of V gamma/V delta gene segments.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8288315      PMCID: PMC1422228     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  35 in total

1.  Specific recognition of staphylococcal enterotoxin A by human T cells bearing receptors with the V gamma 9 region.

Authors:  C J Rust; F Verreck; H Vietor; F Koning
Journal:  Nature       Date:  1990-08-09       Impact factor: 49.962

2.  Serum-inducible expression of transfected human c-myc genes.

Authors:  A Richman; A Hayday
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

3.  Use of a chemically modified T7 DNA polymerase for manual and automated sequencing of supercoiled DNA.

Authors:  F Toneguzzo; S Glynn; E Levi; S Mjolsness; A Hayday
Journal:  Biotechniques       Date:  1988-05       Impact factor: 1.993

4.  Specificity and function of T cells bearing gamma delta receptors.

Authors:  C A Janeway; B Jones; A Hayday
Journal:  Immunol Today       Date:  1988-03

5.  Recognition of cluster of differentiation 1 antigens by human CD4-CD8-cytolytic T lymphocytes.

Authors:  S Porcelli; M B Brenner; J L Greenstein; S P Balk; C Terhorst; P A Bleicher
Journal:  Nature       Date:  1989-10-05       Impact factor: 49.962

6.  T lymphocytes from healthy individuals with specificity to self-epitopes shared by the mycobacterial and human 65-kilodalton heat shock protein.

Authors:  M E Munk; B Schoel; S Modrow; R W Karr; R A Young; S H Kaufmann
Journal:  J Immunol       Date:  1989-11-01       Impact factor: 5.422

7.  Homing of a gamma delta thymocyte subset with homogeneous T-cell receptors to mucosal epithelia.

Authors:  S Itohara; A G Farr; J J Lafaille; M Bonneville; Y Takagaki; W Haas; S Tonegawa
Journal:  Nature       Date:  1990-02-22       Impact factor: 49.962

8.  Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells.

Authors:  M Zijlstra; M Bix; N E Simister; J M Loring; D H Raulet; R Jaenisch
Journal:  Nature       Date:  1990-04-19       Impact factor: 49.962

Review 9.  The staphylococcal enterotoxins and their relatives.

Authors:  P Marrack; J Kappler
Journal:  Science       Date:  1990-05-11       Impact factor: 47.728

10.  CD1b restricts the response of human CD4-8- T lymphocytes to a microbial antigen.

Authors:  S Porcelli; C T Morita; M B Brenner
Journal:  Nature       Date:  1992-12-10       Impact factor: 49.962

View more
  2 in total

1.  The expansion of human gammadelta T cells in response to Daudi cells requires the participation of CD4+ T cells.

Authors:  J D Fayen; M L Tykocinski
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

2.  Germinal center formation, immunoglobulin class switching, and autoantibody production driven by "non alpha/beta" T cells.

Authors:  L Wen; W Pao; F S Wong; Q Peng; J Craft; B Zheng; G Kelsoe; L Dianda; M J Owen; A C Hayday
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.